Evidence map›Paper›PMID 37680529›Full record

ArticleFrontiers in microbiology2023

Grapevines escaping trunk diseases in New Zealand vineyards have a distinct microbiome structure.

Damola O Adejoro, E Eirian Jones, Hayley J Ridgway, Dion C Mundy, Bhanupratap R Vanga, Simon R Bulman

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Impact of the Biocontrol Product, EsquiveJournal of fungi (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Damola O AdejoroDepartment of Pest-Management and Conservation, Faculty of Agriculture and Life Sciences, Lincoln University, Lincoln, Canterbury, New Zealand.
E Eirian JonesDepartment of Pest-Management and Conservation, Faculty of Agriculture and Life Sciences, Lincoln University, Lincoln, Canterbury, New Zealand.
Hayley J RidgwayDepartment of Pest-Management and Conservation, Faculty of Agriculture and Life Sciences, Lincoln University, Lincoln, Canterbury, New Zealand.
Dion C MundyThe New Zealand Institute for Plant and Food Research Limited, Blenheim, Marlborough, New Zealand.
Bhanupratap R VangaThe New Zealand Institute for Plant and Food Research Limited, Lincoln, Canterbury, New Zealand.
Simon R BulmanThe New Zealand Institute for Plant and Food Research Limited, Lincoln, Canterbury, New Zealand.
Lincoln University · NZPlant & Food Research · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Grapevine trunk diseases (GTDs) are a substantial challenge to viticulture, especially with a lack of available control measures. The lack of approved fungicides necessitates the exploration of alternative controls. One promising approach is the investigation of disease escape plants, which remain healthy under high disease pressure, likely due to their microbiome function. This study explored the microbiome of grapevines with the disease escape phenotype. DNA metabarcoding of the ribosomal internal transcribed spacer 1 (ITS1) and 16S ribosomal RNA gene was applied to trunk tissues of GTD escape and adjacent diseased vines. Our findings showed that the GTD escape vines had a significantly different microbiome compared with diseased vines. The GTD escape vines consistently harbored a higher relative abundance of the bacterial taxa

Indexed as

disease escapeEutypagrapevine trunk diseasesmicrobiomePseudomonasVitis vinifera

Identifiers

PMID37680529
PMCPMC10482235
OpenAlexW4386085705

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.